Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season

Funding Opportunity Number: RFA-IP-14-001 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.083Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Dec 09, 2013Award Ceiling: $200,000Expected Number of Awards: 1Creation Date: Oct 31, 2013Funding Opportunity Description: The purpose of this FOA is to provide support for research to determine the effectiveness of empiric influenza antiviral therapy, in addition to standard care, for hospitalized patients with lower respiratory tract illness (LRTI) during the periods when influenza viruses are circulating in the community.
Source: Grants.gov - Category: Research Tags: Health Source Type: funding